Genome-Wide DNA Methylation Identifies Potential Disease-Specific Biomarkers and Pathophysiologic Mechanisms in Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Celiac Disease

By sjmartinez • December 15, 2024

Mahurkar-Joshi S, Thompson M, Villarruel E, Lewis JD, Lin LD, Farid M, Nayeb-Hashemi H, Storage T, Weiss GA, Limketkai BN, Sauk JS, Mayer EA, Chang L. Genome-Wide DNA Methylation Identifies Potential Disease-Specific Biomarkers and Pathophysiologic Mechanisms in Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Celiac Disease. Neurogastroenterol Motil. 2024 Dec 13:e14980. doi: 10.1111/nmo.14980. Epub ahead of print. PMID: 39673136.

Tags: Celiac Disease, Digestive Diseases, DNA Methylation‐Based Biomarkers, inflammatory bowel disease, Irritable Bowel Syndrome, machine learning, Publications

Efficacy and Safety of Ustekinumab and Vedolizumab for Crohn’s Disease of the Pouch

Park S, Keyashian K, Ho A, Limsui D, Frost S, Vazquez R, Yang E, Ebriani J, Maas L, Parian A, Lazarev M, Parekh N, Sauk[...]

Association for Bariatric Endoscopy systematic review and meta-analysis assessing the American Society for Gastrointestinal Endoscopy preservation and incorporation of valuable endoscopic innovations thresholds for transoral outlet reduction

Jirapinyo P, Kumar N, Thompson CC, Law RJ, Muthusamy VR, Schulman AR, Sullivan S. Association for Bariatric Endoscopy systematic review and meta-analysis assessing the American[...]

ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease

Farraye FA, Melmed GY, Lichtenstein GR, Barnes EL, Limketkai BN, Caldera F, Kane S. ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease. Am[...]